Clinical Research Directory
Browse clinical research sites, groups, and studies.
Retinal Neurodegenerative Signs in Alzheimer's Diseases
Sponsor: University Hospital, Bordeaux
Summary
A few studies suggest that patients suffering from neurodegenerative diseases (such a multiple sclerosis or Alzheimer's disease (AD)) show decreased thickness of the retinal nerve fiber layer (RNFL), indicating axonal degeneration. High-definition spectral domain optical coherence tomography (SD-OCT), performed without radiation in a few seconds per eye, offers a precise and standardized estimation of this parameter, which could constitute a biomarker for cerebral axonal degeneration. These RNFL deficits might even be the earliest sign of AD, prior to damage of the hippocampal region that impacts memory. Besides, some associations of AD with some degenerative diseases of the eye (glaucoma, microvascular abnormalities, age-related macular degeneration (AMD)) have also been reported. It therefore seems interesting to determine whether RNFL thickness, and other ocular parameters, may give some indications for a better detection of AD and cognitive decline in the elderly.
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2012-03-12
Completion Date
2014-06-07
Last Updated
2026-05-14
Healthy Volunteers
Yes
Conditions
Interventions
Ophthalmological examination & Questionnaire
The following examinations will be performed, after pupil dilation: * Examination with SD-OCT (macular scans, macular volume, peri-papillary scan, retinal autofluorescence, infer-red and red-free imaging) * Colour photographs of the retinal, centered on the macula and on the optic nerve (digital non mydriatic retinal camera) * Wide-field colour and autofluorescence imaging (Optomap) * Measure of intra-ocular pressure (pneumotonometer) The following informations will be collected through a standardized questionnaire, administered face-to-face during the inclusion visit, or at the moment of the verification of eligibility criteria: * Age, gender * educational level * smoking * cardiovascular diseases, current medications * scores at neuropsychological tests
Locations (1)
CHU Bordeaux - hôpital Pellegrin
Bordeaux, France